EEG at onset and MRI predict long-term clinical outcome in Aicardi syndrome.


Journal

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology
ISSN: 1872-8952
Titre abrégé: Clin Neurophysiol
Pays: Netherlands
ID NLM: 100883319

Informations de publication

Date de publication:
10 2022
Historique:
received: 30 12 2021
revised: 29 06 2022
accepted: 17 07 2022
pubmed: 29 8 2022
medline: 28 9 2022
entrez: 28 8 2022
Statut: ppublish

Résumé

Descriptions of electroencephalographic (EEG) patterns in Aicardi syndrome (AIC) have to date referred to small cohorts of up to six cases and indicated severe derangement of electrical activity in all cases. The present study was conducted to describe the long-term EEG evolution in a larger AIC cohort, followed for up to 23 years, and identify possible early predictors of the clinical and EEG outcomes. In a retrospective study, two experienced clinical neurophysiologists systematically reviewed all EEG traces recorded in 12 AIC cases throughout their follow-up, from epilepsy onset to the present. Clinical outcome was assessed with standardized clinical outcome scales. Analysis of the data revealed two distinct AIC phenotypes. In addition to the "classical severe phenotype" already described in the literature, we identified a new "mild phenotype". The two phenotypes show completely different EEG features at onset of epilepsy and during its evolution, which correspond to different clinical outcomes. Data from our long-term EEG and clinical-neuroradiological study allowed us to describe two different phenotypes of AIC, with different imaging severity and, in particular, different EEG at onset, which tend to remain constant over time. Together, these findings might help to predict long-term clinical outcomes.

Identifiants

pubmed: 36030575
pii: S1388-2457(22)00823-9
doi: 10.1016/j.clinph.2022.07.496
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

112-124

Informations de copyright

Copyright © 2022 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Silvia Masnada (S)

Unit of Pediatric Neurology, V. Buzzi Children's Hospital, Milan, Italy.

Enrico Alfei (E)

Unit of Pediatric Neurology, V. Buzzi Children's Hospital, Milan, Italy.

Manuela Formica (M)

IRCCS Mondino Foundation Department of Neuroradiology, Pavia, Italy.

Roberto Previtali (R)

Unit of Pediatric Neurology, V. Buzzi Children's Hospital, Milan, Italy; University of Milan, Italy.

Patrizia Accorsi (P)

Child Neuropsychiatric Unit, Civilian Hospital, Brescia, Italy.

Filippo Arrigoni (F)

Department of Pediatric Radiology and Neuroradiology, V. Buzzi Children's Hospital, Milan, Italy.

Paolo Bonanni (P)

Scientific Institute, IRCCS E. Medea, Epilepsy and Clinical Neurophysiology Unit, Conegliano, Treviso, Italy.

Renato Borgatti (R)

Department of Brain and Behavioural Neurosciences, University of Pavia, Pavia, Italy; Child Neurology and Psychiatry Unit, IRCCS Mondino Foundation, Pavia, Italy.

Francesca Darra (F)

UOC Child Neuropsychiatry, Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, University of Verona, Italy.

Carlo Fusco (C)

Child Neurology Unit, Pediatric Department, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.

Valentina De Giorgis (V)

Child Neurology and Psychiatry Unit, IRCCS Mondino Foundation, Pavia, Italy.

Lucio Giordano (L)

Child Neuropsychiatric Unit, Civilian Hospital, Brescia, Italy.

Francesca La Briola (F)

Child Neuropsychiatry Unit - Epilepsy Center, San Paolo Hospital, Department of Health Sciences, Università degli Studi di Milano, Milan, Italy.

Simona Orcesi (S)

Department of Brain and Behavioural Neurosciences, University of Pavia, Pavia, Italy; Child Neurology and Psychiatry Unit, IRCCS Mondino Foundation, Pavia, Italy.

Elisa Osanni (E)

Scientific Institute, IRCCS E. Medea, Epilepsy and Clinical Neurophysiology Unit, Conegliano, Treviso, Italy.

Cecilia Parazzini (C)

Department of Pediatric Radiology and Neuroradiology, V. Buzzi Children's Hospital, Milan, Italy.

Lorenzo Pinelli (L)

Department of Neuroradiology, Pediatric Neuroradiology Section, ASST SpedaliCivili, Brescia, Italy.

Erika Rebessi (E)

Child Neuropsychiatry Unit- Sant'Andrea Hospital, Vercelli, Italy.

Romina Romaniello (R)

Neuropsychiatry and Neurorehabilitation Unit, Scientific Institute IRCCS Eugenio Medea, Bosisio Parini, Lecco, Italy.

Antonino Romeo (A)

Pediatric Neurology Unit and Epilepsy Center, Fatebenefratelli Hospital, Milano, Italy.

Carlotta Spagnoli (C)

UOC Child Neuropsychiatry, Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, University of Verona, Italy.

Christian Uebler (C)

KJF Klinik Josefinum gGmbH, Klinik für Kinder und Jugendliche, Neuropädiatrie, Augsburg, Germany.

Costanza Varesio (C)

Department of Brain and Behavioural Neurosciences, University of Pavia, Pavia, Italy; Child Neurology and Psychiatry Unit, IRCCS Mondino Foundation, Pavia, Italy.

Maurizio Viri (M)

Child Neurology and Psychiatry Unit, Maggiore della Carità Hospital, Novara, Italy.

Claudio Zucca (C)

Neurophysiology Unit, Scientific Institute IRCCS Eugenio Medea, Bosisio Parini, Lecco, Italy.

Anna Pichiecchio (A)

Department of Brain and Behavioural Neurosciences, University of Pavia, Pavia, Italy; IRCCS Mondino Foundation Department of Neuroradiology, Pavia, Italy.

Pierangelo Veggiotti (P)

Unit of Pediatric Neurology, V. Buzzi Children's Hospital, Milan, Italy; Department of Biomedical and Clinical Sciences, L. Sacco, University of Milan, Italy. Electronic address: pierangelo.veggiotti@unimi.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH